1. Home
  2. CLDX vs AVDX Comparison

CLDX vs AVDX Comparison

Compare CLDX & AVDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • AVDX
  • Stock Information
  • Founded
  • CLDX 1983
  • AVDX 2000
  • Country
  • CLDX United States
  • AVDX United States
  • Employees
  • CLDX N/A
  • AVDX N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • AVDX EDP Services
  • Sector
  • CLDX Health Care
  • AVDX Technology
  • Exchange
  • CLDX Nasdaq
  • AVDX Nasdaq
  • Market Cap
  • CLDX 1.7B
  • AVDX 1.6B
  • IPO Year
  • CLDX 2008
  • AVDX 2021
  • Fundamental
  • Price
  • CLDX $22.46
  • AVDX $9.22
  • Analyst Decision
  • CLDX Buy
  • AVDX Hold
  • Analyst Count
  • CLDX 8
  • AVDX 15
  • Target Price
  • CLDX $61.86
  • AVDX $11.63
  • AVG Volume (30 Days)
  • CLDX 774.1K
  • AVDX 1.2M
  • Earning Date
  • CLDX 03-04-2025
  • AVDX 02-26-2025
  • Dividend Yield
  • CLDX N/A
  • AVDX N/A
  • EPS Growth
  • CLDX N/A
  • AVDX N/A
  • EPS
  • CLDX N/A
  • AVDX N/A
  • Revenue
  • CLDX $9,976,000.00
  • AVDX $427,566,000.00
  • Revenue This Year
  • CLDX N/A
  • AVDX $17.41
  • Revenue Next Year
  • CLDX N/A
  • AVDX $10.36
  • P/E Ratio
  • CLDX N/A
  • AVDX N/A
  • Revenue Growth
  • CLDX 128.55
  • AVDX 17.84
  • 52 Week Low
  • CLDX $20.91
  • AVDX $7.38
  • 52 Week High
  • CLDX $53.18
  • AVDX $13.56
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 42.55
  • AVDX 25.78
  • Support Level
  • CLDX $22.38
  • AVDX $9.80
  • Resistance Level
  • CLDX $23.69
  • AVDX $10.17
  • Average True Range (ATR)
  • CLDX 1.07
  • AVDX 0.29
  • MACD
  • CLDX 0.03
  • AVDX -0.11
  • Stochastic Oscillator
  • CLDX 44.67
  • AVDX 3.24

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

About AVDX AvidXchange Holdings Inc.

AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.

Share on Social Networks: